Crotoxin: Novel activities for a classic beta-neurotoxin

dc.contributor.authorSampaio, Sandra C.
dc.contributor.authorHyslop, Stephen
dc.contributor.authorFontes, Marcos R. M. [UNESP]
dc.contributor.authorPrado-Franceschi, Julia
dc.contributor.authorZambelli, Vanessa O.
dc.contributor.authorMagro, Angelo J. [UNESP]
dc.contributor.authorBrigatte, Patricia
dc.contributor.authorGutierrez, Vanessa P.
dc.contributor.authorCury, Yara
dc.contributor.institutionInstituto Butantan
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:49:30Z
dc.date.available2014-05-20T13:49:30Z
dc.date.issued2010-06-01
dc.description.abstractCrotoxin, the main toxin of South American rattlesnake (Crotalus durissus terrificus) venom, was the first snake venom protein to be purified and crystallized. Crotoxin is a heterodimeric beta-neurotoxin that consists of a weakly toxic basic phospholipase A(2) and a nonenzymatic, non-toxic acidic component (crotapotin). The classic biological activities normally attributed to crotoxin include neurotoxicity, myotoxicity, nephrotoxicity and cardiotoxicity. However, numerous studies in recent years have shown that crotoxin also has immunomodulatory, anti-inflammatory, anti-microbial, anti-tumor and analgesic actions. In this review, we describe the historical background to the discovery of crotoxin and its main toxic activities and then discuss recent structure-function studies and investigations that have led to the identification of novel pharmacological activities for the toxin. (C) 2010 Elsevier Ltd. All rights reserved.en
dc.description.affiliationInst Butantan, Lab Fisiopatol, BR-05503900 São Paulo, Brazil
dc.description.affiliationUniv Estadual Campinas, Dept Pharmacol, Fac Med Sci, BR-13083970 Campinas, SP, Brazil
dc.description.affiliationUniv Estadual Paulista, Dept Phys & Biophys, Inst Biosci, BR-18618000 Botucatu, SP, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, Dept Phys & Biophys, Inst Biosci, BR-18618000 Botucatu, SP, Brazil
dc.format.extent1045-1060
dc.identifierhttp://dx.doi.org/10.1016/j.toxicon.2010.01.011
dc.identifier.citationToxicon. Oxford: Pergamon-Elsevier B.V. Ltd, v. 55, n. 6, p. 1045-1060, 2010.
dc.identifier.doi10.1016/j.toxicon.2010.01.011
dc.identifier.issn0041-0101
dc.identifier.urihttp://hdl.handle.net/11449/17648
dc.identifier.wosWOS:000276436600001
dc.language.isoeng
dc.publisherPergamon-Elsevier B.V. Ltd
dc.relation.ispartofToxicon
dc.relation.ispartofjcr2.352
dc.relation.ispartofsjr0,692
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectAnti-inflammatoryen
dc.subjectAnti-microbialen
dc.subjectAntinociceptionen
dc.subjectAnti-tumor activityen
dc.subjectCrotoxinen
dc.subjectImmunomodulationen
dc.subjectNeurotoxicityen
dc.titleCrotoxin: Novel activities for a classic beta-neurotoxinen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderPergamon-Elsevier B.V. Ltd
unesp.author.lattes0059017255172730[6]
unesp.author.orcid0000-0002-6245-3166[9]
unesp.author.orcid0000-0002-4634-6221[3]
unesp.author.orcid0000-0003-2796-4187[7]
unesp.author.orcid0000-0002-4253-6992[6]
unesp.campusUniversidade Estadual Paulista (Unesp), Instituto de Biociências, Botucatupt

Arquivos

Licença do Pacote

Agora exibindo 1 - 2 de 2
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: